Like Carlos Ghosn before him, Ivan Espinosa is trying to return the carmaker to profitability—and ensure it survives. ...

Major indexes snapped a three-day losing streak. ...

Core Viewpoint - Drugmakers are preparing for potential levies and are proactively committing to invest billions in domestic manufacturing [1] Group 1 - Drugmakers are bracing for upcoming levies [1] - Companies are seeking to get ahead of these levies by pledging significant investments [1] - The focus of these investments is on enhancing domestic manufacturing capabilities [1]

Core Viewpoint - Investors, including Silver Lake, are considering a deal that could potentially become the largest leveraged buyout in history [1] Group 1 - The involvement of prominent investors like Silver Lake indicates strong market interest and confidence in the potential deal [1] - The deal is expected to set a new record for leveraged buyouts, highlighting the increasing trend of such financial transactions in the current market environment [1]

Sinclair said it will end its pre-emption of "Jimmy Kimmel Live!†and air the late-night show again beginning Friday. ...

Core Viewpoint - Investors are focusing on U.S. jobs data, as any signs of weakness could lead to expectations of interest-rate cuts in the near future [1] Group 1 - The U.S. jobs data is a critical indicator for investors [1] - Weakness in jobs data may trigger a series of interest-rate cuts [1]

Core Point - AstraZeneca will offer discounts of up to 70% on its asthma and diabetes drugs in the U.S. in response to a deadline set by the Trump administration for pharmaceutical companies to reduce drug prices [1] Company Summary - AstraZeneca is taking proactive measures to comply with upcoming regulations aimed at lowering drug prices [1] - The company's decision reflects a broader trend in the pharmaceutical industry to address pricing pressures and enhance accessibility for patients [1] Industry Summary - The pharmaceutical industry is facing increasing scrutiny and pressure to reduce drug prices, particularly in the U.S. market [1] - The move by AstraZeneca may set a precedent for other companies in the industry to follow suit in order to meet regulatory expectations [1]

The monthly survey's sentiment index fell to 55.1 in September, from 58.2 in August amid worries about high prices and the labor market. ...

New funds try to defer tax payments but don't yet have a proven record. ...

Core Viewpoint - Boeing is anticipated to regain some authority from regulators to conduct final safety checks on jets [1] Group 1 - The company is expected to enhance its operational capabilities by performing final safety checks, which may lead to improved efficiency in the production process [1]